Holen Sie sich die Stockscreener-App
197.68
5.23%
9.83
Handel nachbörslich:
197.68
Schlusskurs vom Vortag:
$187.85
Offen:
$191.44
24-Stunden-Volumen:
1.56M
Relative Volume:
1.35
Marktkapitalisierung:
$28.02B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$-208.16M
KGV:
-128.65
EPS:
-1.5366
Netto-Cashflow:
$76.11M
1W Leistung:
-3.67%
1M Leistung:
-4.15%
6M Leistung:
+12.95%
1J Leistung:
+33.37%
1-Tages-Spanne:
$190.66
$198.18
1-Wochen-Bereich:
$186.07
$207.08
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
197.68 | 26.62B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
470.00 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
191.39 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
586.37 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.83 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
290.02 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Why Natera Stock Is Surging On Fresh Optimism - TipRanks
NTRA Debuts Zenith Genomics Next-Gen Sequencing Test for Rare Diseases - Yahoo Finance
Natera ctDNA test shows promise in anal, rectal cancer studies - Investing.com
Natera ctDNA test shows promise in anal, rectal cancer studies By Investing.com - Investing.com India
Fred Alger Management LLC Buys 41,303 Shares of Natera, Inc. $NTRA - MarketBeat
Farallon Capital Management LLC Sells 568,357 Shares of Natera, Inc. $NTRA - MarketBeat
Cancer DNA test ties anal and rectal tumors to relapse odds - Stock Titan
Coatue Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Capital Impact Advisors LLC Boosts Stock Position in Natera, Inc. $NTRA - MarketBeat
Aquatic Capital Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat
Pinnbrook Capital Management LP Makes New $5.78 Million Investment in Natera, Inc. $NTRA - MarketBeat
Guidance Update: Can Natera Inc keep up with sector leadersPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Natera Launches Zenith Genomics To Expand Rare Disease Testing Story - simplywall.st
Zenith Genomics Launch Could Be A Game Changer For Natera’s (NTRA) Rare Disease Strategy - Yahoo Finance
Meridiem Capital Partners LP Invests $11.90 Million in Natera, Inc. $NTRA - MarketBeat
Quantitative Investment Management LLC Acquires 6,152 Shares of Natera, Inc. $NTRA - MarketBeat
16,650 Shares in Natera, Inc. $NTRA Purchased by Magnetar Financial LLC - MarketBeat
Korea Investment CORP Cuts Position in Natera, Inc. $NTRA - MarketBeat
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - Sahm
MyOme Debuts Zenithtm Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - lelezard.com
Natera launches whole genome sequencing test for rare diseases - Investing.com South Africa
[144] Natera, Inc. SEC Filing - Stock Titan
GeneDx stock falls as Natera launches competing rare disease test - Investing.com UK
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Natera announces commercial launch of Zenith genomics - TipRanks
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - BioSpace
Natera, Inc. $NTRA Shares Sold by Swiss National Bank - MarketBeat
Natera, Inc. $NTRA Shares Bought by Franklin Resources Inc. - MarketBeat
Capital Fund Management S.A. Buys 41,307 Shares of Natera, Inc. $NTRA - MarketBeat
Natera director Sheena Jonathan sells $25924 in stock - Investing.com Australia
Natera president Fesko sells $144k in shares By Investing.com - Investing.com Canada
Natera: Daniel Rabinowitz sells $356k in shares - Investing.com
Natera president Fesko sells $144k in shares - Investing.com
Natera director Sheena Jonathan sells $25924 in stock By Investing.com - Investing.com India
Natera: Daniel Rabinowitz sells $356k in shares By Investing.com - Investing.com India
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 5,623 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 707 Shares of Stock - MarketBeat
Michael Burkes Brophy Sells 785 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CFO Brophy sells $160k in NTRA stock - Investing.com
Natera CEO Steven Chapman sells $1.15 million in shares - Investing.com
Natera Is Quietly Raising Signatera Pricing Power — Could This Hidden Catalyst Supercharge Revenue Growth? - Smartkarma
Natera (NASDAQ: NTRA) president awarded RSUs, sells shares for tax - Stock Titan
Natera (NTRA) co-founder reports RSU grant and small tax-driven share sale - Stock Titan
Natera (NASDAQ:NTRA) Insider Sells $186,778.95 in Stock - MarketBeat
The Bull Case For Natera (NTRA) Could Change Following 2026 Guidance And New Signatera Bladder Data - simplywall.st
Natera at Leerink Global Healthcare Conference: Strategic Growth and Investment By Investing.com - Investing.com
Natera (NTRA) legal chief exercises 5,598 options and sells 8,398 shares - Stock Titan
Natera Officer Daniel Rabinowitz Sells Shares - TradingView
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
3 Healthcare Stocks to Target This Week - Finviz
Evercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating - MSN
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):